Interleukin-1 as an adjuvant for tumor vaccines increases survival in mice.
McCune
C
C
University of Rochester Cancer Center, Department of Medicine, NY 14642.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000818:Animals; D006801:Humans; D007167:Immunotherapy; D007375:Interleukin-1 / Q000627:therapeutic use*; D051379:Mice; D008807:Mice, Inbred BALB C; D009374:Neoplasms, Experimental / Q000276:immunology / Q000628:therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D007375:Interleukin-1; D011994:Recombinant Proteins